Ahead of adcomm for full approval, FDA estimates Pfizer's Covid pill could save 1,500 lives per week
Ahead of Thursday’s meeting of the FDA’s Antimicrobial Drugs Advisory Committee, which will decide whether to flip Pfizer’s blockbuster Covid-19 pill from an EUA to …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
